Drugs / egg-derived influenza subunit vaccine
egg-derived influenza subunit vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00306527 Comparator | Sep → Dec 2005 | influenza | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | egg-derived influenza subunit vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00306527 ↗ |
| Known as | Agrippal() | “egg-derived (TIV; Agrippal(®)) trivalent influenza vaccines” PMID 22418809 ↗ May 2012 |
| Known as | TIV | “egg-derived (TIV; Agrippal(®)) trivalent influenza vaccines” PMID 22418809 ↗ May 2012 |
| Modality | Vaccine | “egg-derived (TIV; Agrippal(®)) trivalent influenza vaccines” PMID 22418809 ↗ May 2012 |
| Route | Intramuscular | “as a single IM injection of 0.5 ml in the deltoid muscle, preferably of the non-dominant arm” NCT00306527 ↗ |